News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Emergent BioSolutions
NEWS
JOBS
IN THE PRESS
NEWS
Deals
Evolva A/S Unloads EV-035 Series To Emergent BioSolutions For $70.5 Million Plus
December 17, 2014
·
1 min read
Business
Drugmakers Like Johnson & Johnson, Emergent BioSolutions, And Mapp Biopharmaceutical Stand To Gain Ebola Contracts Worth $2 Billion
November 11, 2014
·
1 min read
Biotech Beach
The Day In Review: BioSimilar Drug Enters Trial
March 21, 2007
·
1 min read
Biotech Beach
The Day In Review: Allergan Inc. Expands Obesity Franchise
February 23, 2007
·
1 min read
Deals
IPO Watch: Emergent BioSolutions Makes Anthrax Vaccine
November 16, 2006
·
1 min read
Biotech Beach
The Week In Review: Strong Gain; Stronger Breadth
August 21, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
January 15, 2026
·
5 min read
Press Releases
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
January 12, 2026
·
2 min read
Press Releases
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
January 9, 2026
·
3 min read
Press Releases
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
January 8, 2026
·
3 min read
Press Releases
Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
January 7, 2026
·
1 min read
Press Releases
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
December 15, 2025
·
4 min read
Press Releases
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
November 19, 2025
·
10 min read
Press Releases
Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors
November 13, 2025
·
1 min read
Press Releases
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
October 30, 2025
·
38 min read
Press Releases
Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025
October 9, 2025
·
1 min read
